Annual Accounts Receivable
N/A
December 31, 2023
Summary
- COCP annual accounts receivable is not available.
Performance
COCP Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- COCP quarterly accounts receivable is not available.
Performance
COCP Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
COCP Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
COCP Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Cocrystal Pharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $556.00 K(-13.7%) | $556.00 K(-4.3%) |
| Sep 2020 | - | $581.00 K(-1.9%) |
| Jun 2020 | - | $592.00 K(-8.1%) |
| Mar 2020 | - | $644.00 K(0.0%) |
| Dec 2019 | $644.00 K(>+9900.0%) | $644.00 K(-16.1%) |
| Sep 2019 | - | $768.00 K(-16.0%) |
| Jun 2019 | - | $914.00 K(-15.2%) |
| Mar 2019 | - | $1.08 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $21.00 K | $21.00 K(+31.3%) |
| Sep 2016 | - | $16.00 K(+23.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $13.00 K(-18.8%) |
| Mar 2016 | - | $16.00 K(-50.0%) |
| Dec 2015 | $32.00 K(-73.8%) | $32.00 K(+166.7%) |
| Sep 2015 | - | $12.00 K(-29.4%) |
| Jun 2015 | - | $17.00 K(-88.4%) |
| Mar 2015 | - | $146.00 K(+19.7%) |
| Dec 2014 | $122.00 K(>+9900.0%) | $122.00 K(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2013 | - | $50.30 K(-92.8%) |
| Jun 2013 | - | $702.00 K(+24.6%) |
| Mar 2013 | - | $563.30 K(-38.7%) |
| Sep 2012 | - | $919.50 K(-27.1%) |
| Jun 2012 | - | $1.26 M(+21.7%) |
| Mar 2012 | - | $1.04 M(+98.2%) |
| Dec 2011 | $523.00 K(-62.6%) | $523.00 K(-71.4%) |
| Sep 2011 | - | $1.83 M(+9.3%) |
| Jun 2011 | - | $1.67 M(+19.6%) |
| Dec 2010 | $1.40 M | $1.40 M |
FAQ
- What is the all time high annual accounts receivable for Cocrystal Pharma?
- What is the all time high quarterly accounts receivable for Cocrystal Pharma?
What is the all time high annual accounts receivable for Cocrystal Pharma?
Cocrystal Pharma all-time high annual accounts receivable is $1.40 M
What is the all time high quarterly accounts receivable for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly accounts receivable is $1.83 M